Vista Pharmaceuticals to Consider Q4 & FY26 Results on 29-May-26
Vista Pharmaceuticals Ltd 路 Intimation 路 29 May 2026, 5:30 am
Vista Pharmaceuticals to Consider Q4 & FY26 Results on 29-May-26 Vista Pharmaceuticals (BSE: 524711) has scheduled a Board of Directors meeting for Fri, 29th May'26. The agenda includes the consideration and approval of the audited financial results and the audit report for the quarter and financial year ended 31st Mar'26.
Original exchange filing (PDF)
More announcements from Vista Pharmaceuticals Ltd
- Resignation of Company Secretary & Compliance Officer 路 12 Sept 2026
- Results for the quarter ended 30.06.2026 路 14 Aug 2026
- Results for the quarter ended 30.06.2026 路 14 Aug 2026
- Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. Unaudited financial .... 路 14 Aug 2026
- Board meeting outcome 路 29 May 2026
- <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> .... 路 29 Apr 2026
- Un audited Financial Results for the quarter ended 31.12.2025 路 13 Feb 2026
- Results for the quarter ended 31.12.2025 路 13 Feb 2026
